HCW Biologics terminates Wugen license, regains ex vivo rights to HCW9201/9206 at no cost

HCW Biologics Inc.

Company exercised option to terminate exclusive worldwide license from Wugen for ex vivo rights to HCW9201 and HCW9206; regained rights at no cost.
Retained nonrefundable upfront license fee including 2.2 million shares of Wugen common stock.
Recent data in Science Advances suggests HCW9206 may reduce CAR-T production costs and improve therapeutic efficacies.
Company plans to commercialize the reagents through partners focused on CAR-T and NK-cell therapies.

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001493152-26-025336
form_type: 8-K
ticker: HCWB
cik: 0001828673
company_name: HCW Biologics Inc.
filed_at: 2026-05-27T12:00:25+00:00
discovered_at: 2026-05-27T12:05:02.477205+00:00
generated_at: 2026-05-27T12:07:48.057217+00:00
sec_items: ["1.02", "9.01"]
event_type: other_material
sentiment: positive
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001493152-26-025336
json_url: https://secwatch.observer/filing/0001493152-26-025336.json
markdown_url: https://secwatch.observer/filing/0001493152-26-025336.md
text_url: https://secwatch.observer/filing/0001493152-26-025336.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1828673/000149315226025336/0001493152-26-025336-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1828673/000149315226025336/form8-k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

Barings BDC receives $67M cash from adviser, enters new $11M credit support for Sierra legacy investments

Barings BDC, Inc. June 1, 2026, 4:15 PM ET other_material Items 1.01, 1.02, 9.01

same SEC item: 1.02, 9.01 same event type: other_material similar materiality

Selling stockholders price upsized secondary offering of 14M shares at $61/share for ~$854M gross proceeds

Karman Holdings Inc. June 1, 2026, 5:28 PM ET other_material Items 1.01, 7.01, 8.01, 9.01